Inspection Record

AbbVie Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-06-13 8 findingsMaterial and supplier controlDeviation, CAPA, and investigationEquipment and facilityOther quality systemContamination control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Material and supplier control

The premises and/or the manufacturing process were inadequate for minimizing contamination of the drugs and/or materials during fabrication and/or packaging.

2Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

3Equipment and facility

The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination. The equipment was not set-up, designed, operated, stored, and/or maintained to prevent potential contamination of drugs by other drugs and/or by foreign material.

4Other quality system

The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate. The recorded information or details were inadequate.

5Other quality system

The suitability of the culture media was not verified.

6Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

7Equipment and facility

The equipment was not set-up, designed, operated, stored, and/or maintained to prevent potential contamination of drugs by other drugs and/or by foreign material. The preventative maintenance program was inadequate for the equipment used in significant processing and/or testing operations.

8Contamination control

The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-06-13. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

AbbVie Inc. findings history — including this company's other documents Health Canada documents, 2022 Go to Findings search